case_images: PMC11284616_01
case_images: Representative MRI imaging and PET-CT maps at the end of 8 cycles of combination therapy. (A-C) At the end of the combined treatment, the liver enhanced MRI axial T1 weighted images of artery, portal vein and balance phase showed no obvious enhancement of the tumor. (D) Increased 18F-FDG metabolism of the mass is seen on PET-CT of the liver tumor before combination therapy. (E) significant decrease in 18F-FDG metabolism in the visible mass of liver tumor PET-CT at the end of combination therapy. (F) H&E staining results of liver tumor biopsy guided by ultrasound.
case_images: fonc-14-1428370-g001.jpg
case_images: PMC11284616_01_fonc-14-1428370-g001.jpg
case_images: f1
case_images: Pathological examination ( Figure 1F ) showed intrahepatic cholangiocarcinoma.